Keynote 42: Pembrolizumab, PD-L1, and where to draw the line.

ABSTRACT:

SUBMITTER: Isaacs J 

PROVIDER: S-EPMC7210198 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature